0001225208-19-011284.txt : 20190813 0001225208-19-011284.hdr.sgml : 20190813 20190813165444 ACCESSION NUMBER: 0001225208-19-011284 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190809 FILED AS OF DATE: 20190813 DATE AS OF CHANGE: 20190813 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CAHILL JOHN T CENTRAL INDEX KEY: 0001197000 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-00644 FILM NUMBER: 191021449 MAIL ADDRESS: STREET 1: LEGG MASON, INC. STREET 2: 100 INTERNATIONAL DRIVE CITY: BALTIMORE STATE: MD ZIP: 21202 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: COLGATE PALMOLIVE CO CENTRAL INDEX KEY: 0000021665 STANDARD INDUSTRIAL CLASSIFICATION: PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844] IRS NUMBER: 131815595 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 2123102000 MAIL ADDRESS: STREET 1: 300 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10022 4 1 doc4.xml X0306 4 2019-08-09 0000021665 COLGATE PALMOLIVE CO CL 0001197000 CAHILL JOHN T C/O COLGATE-PALMOLIVE COMPANY 300 PARK AVENUE NEW YORK NY 10022 1 Common Stock 2019-08-09 4 M 0 8000.0000 40.6000 A 30326.0000 D Common Stock 2019-08-09 4 S 0 8000.0000 71.4309 D 22326.0000 D Common Stock 23143.0000 I By Trust Stock Option (Right to Buy) 40.6000 2019-08-09 4 M 0 8000.0000 0.0000 D 2020-02-17 Common Stock 8000.0000 0.0000 D Exercise of stock options awarded under the issuer's Non-Employee Director Stock Option Plan. Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's Non-Employee Director Stock Option Plan. Weighted average price, as these shares were sold in multiple transactions at prices ranging from $71.37 to $71.50, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. This amount includes 2,515 shares that were previously reported as directly beneficially owned. Option became exercisable in one-third increments beginning on the first anniversary of the February 17, 2010 grant date. /s/ Kristine Hutchinson, Attorney-in-Fact 2019-08-13